Université Grenoble Alpes, INSERM, CEA, U1292 Biosanté, CNRS EMR BRM, Grenoble cedex, France.
CNRS, Grenoble Institute of Technology, LMGP, UMR, Grenoble, France.
Biotechnol J. 2024 Sep;19(9):e2400007. doi: 10.1002/biot.202400007.
Bone morphogenetic proteins (BMPs) and transforming growth factors (TGF-β) are members of the TGF-β superfamily, known for their roles in several physiological and pathological processes. These factors are known to bind in vivo to BMP and TGF-β receptors, respectively, which induces the phosphorylation of Smad (pSmad) transcription factors. This pathway is generally studied with Western blot and luciferase bioluminescence assay, which presents some limitations.
In this work, we developed and optimized a high-throughput assay to study pSmad pathways using immunofluorescence (IF) as an alternative to Western blot. We aimed to overcome the technical challenges usually faced in the classical IF assay in image acquisition, analysis, and quantification.
We used C2C12 cells as a cellular model. The cells were stimulated with BMP-2 and TGF-β1 that were delivered either in solution (soluble) or via a biomaterial presenting the growth factor (GF), that is in a "matrix-bound" manner. Image acquisition parameters, analysis methods, and quantification of pSmads using IF were optimized for cells cultured on two types of supports: on bare glass and on a biomimetic coating made by self-assembly of the biopolymers hyaluronic acid and poly(l-lysine), which was crosslinked and then loaded with the GFs.
We performed high-content kinetic studies of pSmad expression for cells cultured in 96-well microplates in response to soluble and matrix-bound BMP-2 and TGF-β1. The detection limit of the IF-based assay was found to be similar to Western blot. Additionally, we provide a proof-of-concept for drug testing using inhibitors of BMP and TGF-β receptors, under conditions where specific signaling pathways are engaged via the ligand/receptor interactions. Altogether, our findings offer perspectives for future mechanistic studies on cell signaling and for studies at the single cell level using imaging methods.
骨形态发生蛋白(BMPs)和转化生长因子(TGF-β)是 TGF-β 超家族的成员,其在多种生理和病理过程中发挥作用而闻名。这些因子已知分别与 BMP 和 TGF-β 受体结合,从而诱导 Smad(pSmad)转录因子的磷酸化。该途径通常通过 Western blot 和荧光素酶生物发光测定法进行研究,但这些方法存在一些局限性。
在这项工作中,我们开发并优化了一种高通量测定法,以使用免疫荧光(IF)作为 Western blot 的替代方法来研究 pSmad 途径。我们旨在克服经典 IF 测定法在图像获取、分析和定量方面通常面临的技术挑战。
我们使用 C2C12 细胞作为细胞模型。用 BMP-2 和 TGF-β1 刺激细胞,这些生长因子通过溶液(可溶性)或通过呈现生长因子的生物材料(即基质结合方式)递送来刺激细胞。针对在两种类型的支持物上培养的细胞(裸玻璃和通过自组装生物聚合物透明质酸和聚(L-赖氨酸)制成的仿生涂层,然后交联并加载生长因子)优化了 IF 中 pSmads 的图像获取参数、分析方法和定量。
我们对在 96 孔微孔板中培养的细胞进行了可溶性和基质结合的 BMP-2 和 TGF-β1 反应的 pSmad 表达的高内涵动力学研究。发现 IF 测定法的检测限与 Western blot 相似。此外,我们还提供了在通过配体/受体相互作用激活特定信号通路的情况下,使用 BMP 和 TGF-β 受体抑制剂进行药物测试的概念验证。总之,我们的研究结果为使用成像方法进行细胞信号转导的机制研究和单细胞水平的研究提供了新的视角。